6 days ago
TNGX
AnalystsKelsey GoodwinKelsey Goodwin's Stock Forecasts
AnalystsKelsey Goodwin
Sectors:
Industries:
Analyst Ranking
Top 13%
#652 out of 5179 analysts
Average Return
+33.36%
Win Rate
69%20 out of 29
Risk vs Reward
Poor
Good
Kelsey Goodwin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Century Therapeutics IncIPSC | +267.57% | $0.56 | $2.04 | 2025-03-20 - 2026-01-21 | Strong Buy |
Revolution Medicines IncRVMD | +221.65% | $36.54 | $117.53 | 2025-08-18 - 2026-01-21 | Strong Buy |
Genelux CorpGNLX | +147.25% | $3.09 | $7.64 | 2024-10-28 - 2025-10-28 | Strong Buy |
Cg Oncology IncCGON | +123.51% | $25.56 | $57.13 | 2025-08-18 - 2026-01-21 | Strong Buy |
Erasca IncERAS | +94.39% | $5.17 | $10.05 | 2026-01-06 - 2026-01-21 | Strong Buy |
Kelsey Goodwin Analyst Color
Get additional color on Kelsey Goodwin's coverage of popular stocks
6 days ago
ERAS
7 days ago
CGON
3 months ago
DAWN
3 months ago
NUVL
Kelsey Goodwin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tango Therapeutics IncTNGX | 2 | Strong Buy | $14.00 | +11.91% | Maintains | 6 days ago |
Janux Therapeutics IncJANX | 2 | Strong Buy | $30.00 | +126.07% | Maintains | 6 days ago |
Erasca IncERAS | 2 | Strong Buy | $11.00 | +9.45% | Maintains | 6 days ago |
Cg Oncology IncCGON | 2 | Strong Buy | $70.00 | +22.53% | Maintains | 7 days ago |
Black Diamond Therapeutics IncBDTX | 2 | Strong Buy | $8.00 | +211.28% | Maintains | 7 days ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $24.00 | +315.94% | Initiates Coverage On | 16 days ago |
Oric Pharmaceuticals IncORIC | 1 | Strong Buy | $22.00 | +79.59% | Initiates Coverage On | 16 days ago |
Day One Biopharmaceuticals IncDAWN | 1 | Strong Buy | $26.00 | +115.41% | Maintains | 3 months ago |
Nuvalent IncNUVL | 4 | Strong Buy | $128.00 | +17.39% | Maintains | 3 months ago |
Summit Therapeutics IncSMMT | 1 | Hold | $21.00 | +24.63% | Initiates Coverage On | 5 months ago |
Revolution Medicines IncRVMD | 1 | Strong Buy | $75.00 | -36.19% | Initiates Coverage On | 5 months ago |
Urogen Pharma LtdURGN | 3 | Strong Buy | $36.00 | +87.21% | Initiates Coverage On | 5 months ago |
Bicara Therapeutics IncBCAX | 1 | Strong Buy | $36.00 | +112.14% | Initiates Coverage On | 5 months ago |
Century Therapeutics IncIPSC | 2 | Strong Buy | $5.00 | +145.10% | Maintains | 10 months ago |
Genelux CorpGNLX | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
2seventy Bio IncTSVT | 2 | Strong Buy | $26.00 | N/A | Maintains | 2 years ago |
Arcellx IncACLX | 2 | Strong Buy | $58.00 | N/A | Maintains | 3 years ago |
Legend Biotech CorpLEGN | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Iovance Biotherapeutics IncIOVA | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.